Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2026 Filed Sep 2, 2026 23:05 UTC |
Yu YongChief Scientific Officer
|
SaleCommon Stock | 9,683 | $2.75 | $26,658.27 |
DisclosureSEC source: 0001493152-26-041283 · ownership.xml · nonDerivative · entry 1 Yu Yong · CIK 0001937482 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,688 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $2.7531, and the range of prices were between $2.70 and $2.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 23:05 UTC |
Zindrick ThomasPresident and CEO
|
SaleCommon Stock | 34,463 | $2.67 | $91,899.04 |
DisclosureSEC source: 0001493152-26-041284 · ownership.xml · nonDerivative · entry 1 Zindrick Thomas · CIK 0001937573 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,226,427 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $2.6666, and the range of prices were between $2.59 and $2.81. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided Read SEC document |
| August 31, 2026 Filed Sep 2, 2026 23:05 UTC |
Cappello JosephChief Technical Officer
|
SaleCommon Stock | 10,257 | $2.74 | $28,112.39 |
DisclosureSEC source: 0001493152-26-041285 · ownership.xml · nonDerivative · entry 1 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 318,480 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $2.7408, and the range of prices were between $2.70 and $2.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 00:20 UTC |
Cappello JosephChief Technical Officer
|
SaleCommon Stock | 653 | $2.95 | $1,924.20 |
DisclosureSEC source: 0001493152-26-036076 · ownership.xml · nonDerivative · entry 1 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,737 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $2.9467, and the range of prices were between $2.91 and $2.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 00:20 UTC |
Yu YongChief Scientific Officer
|
SaleCommon Stock | 653 | $2.94 | $1,922.04 |
DisclosureSEC source: 0001493152-26-036077 · ownership.xml · nonDerivative · entry 1 Yu Yong · CIK 0001937482 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,371 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $2.9434, and the range of prices were between $2.93 and $2.975. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 04, 2026 Filed Aug 5, 2026 00:20 UTC |
Zindrick ThomasPresident and CEO
|
SaleCommon Stock | 3,023 | $2.95 | $8,905.46 |
DisclosureSEC source: 0001493152-26-036075 · ownership.xml · nonDerivative · entry 1 Zindrick Thomas · CIK 0001937573 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,260,890 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $2.9459, and the range of prices were between $2.905 and $2.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:35 UTC |
Smither John WDirector
|
SaleCommon Stock | 12,000 | $2.91 | $34,898.40 |
DisclosureSEC source: 0001493152-26-031927 · ownership.xml · nonDerivative · entry 1 Smither John W · CIK 0001559583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,403 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $2.9082, and the range of prices were between $2.87 and $2.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 23:05 UTC |
Pulisic MatthewChief Financial Officer
|
GrantCommon Stock | 278,906 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-029421 · ownership.xml · nonDerivative · entry 1 Pulisic Matthew · CIK 0002054836 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,906 F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 23:05 UTC |
Cappello JosephChief Technical Officer
|
GrantCommon Stock | 174,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-029419 · ownership.xml · nonDerivative · entry 1 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,390 F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 23:05 UTC |
Groen EricGeneral Counsel
|
GrantCommon Stock | 233,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-029420 · ownership.xml · nonDerivative · entry 1 Groen Eric · CIK 0001918630 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,957 F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 23:05 UTC |
Tyree James LDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,566 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0001493152-26-029418 · ownership.xml · derivative · entry 2 Tyree James L · CIK 0001324991 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,566 Underlying: Common stock · 31,566 shares Expires 2036-06-15 F2 · derivative.exercise_date: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 23:05 UTC |
Tyree James LDirector
|
GrantCommon Stock | 28,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-029418 · ownership.xml · nonDerivative · entry 1 Tyree James L · CIK 0001324991 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,483 F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 23:05 UTC |
Thomas JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,566 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0001493152-26-029416 · ownership.xml · derivative · entry 2 Thomas John · CIK 0001939103 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,566 Underlying: Common stock · 31,566 shares Expires 2036-06-15 F2 · derivative.exercise_date: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 23:05 UTC |
Thomas JohnDirector
|
GrantCommon Stock | 28,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-029416 · ownership.xml · nonDerivative · entry 1 Thomas John · CIK 0001939103 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 501,193 F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 23:05 UTC |
Zindrick ThomasPresident and CEO
|
GrantCommon Stock | 730,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-029417 · ownership.xml · nonDerivative · entry 1 Zindrick Thomas · CIK 0001937573 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,263,913 F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter. F2 · balance_after: Includes 1261 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 23:05 UTC |
Mirabelli MaryDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,566 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0001493152-26-029415 · ownership.xml · derivative · entry 2 Mirabelli Mary · CIK 0001937525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,566 Underlying: Common stock · 31,566 shares Expires 2036-06-15 F2 · derivative.exercise_date: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 23:05 UTC |
Mirabelli MaryDirector
|
GrantCommon Stock | 28,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-029415 · ownership.xml · nonDerivative · entry 1 Mirabelli Mary · CIK 0001937525 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,693 F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 23:05 UTC |
Yu YongChief Scientific Officer
|
GrantCommon Stock | 119,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-029414 · ownership.xml · nonDerivative · entry 1 Yu Yong · CIK 0001937482 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,024 F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest 25% on the first anniversary of the date of grant, and the remaining shares shall vest in 12 equal quarterly (every 3 months) installments thereafter. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 23:05 UTC |
Smither John WDirector
|
GrantStock Option (Right to Buy) · Derivative | 31,566 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0001493152-26-029413 · ownership.xml · derivative · entry 2 Smither John W · CIK 0001559583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,566 Underlying: Common stock · 31,566 shares Expires 2036-06-15 F2 · derivative.exercise_date: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 23:05 UTC |
Smither John WDirector
|
GrantCommon Stock | 28,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-029413 · ownership.xml · nonDerivative · entry 1 Smither John W · CIK 0001559583 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,403 F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 00:35 UTC |
Smalling RalphHead of Regulatory
|
SaleCommon Stock | 192 | $2.93 | $562.56 |
DisclosureSEC source: 0001493152-26-027348 · ownership.xml · nonDerivative · entry 1 Smalling Ralph · CIK 0001983288 · Head of Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,611 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 00:35 UTC |
Thomas JohnDirector
|
SaleCommon Stock | 10,000 | $2.98 | $29,801.00 |
DisclosureSEC source: 0001493152-26-026930 · ownership.xml · nonDerivative · entry 1 Thomas John · CIK 0001939103 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 472,784 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2025. F2 · price: The weighted average sale price for the transaction reported was $2.9801, and the range of prices were between $2.94 and $3.05. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 11, 2026 Filed May 13, 2026 00:30 UTC |
Cappello JosephChief Technical Officer
|
SaleCommon Stock | 605 | $2.97 | $1,799.39 |
DisclosureSEC source: 0001493152-26-022568 · ownership.xml · nonDerivative · entry 1 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,549 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $2.9742, and the range of prices were between $2.96 and $3.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 11, 2026 Filed May 13, 2026 00:30 UTC |
Yu YongChief Scientific Officer
|
SaleCommon Stock | 605 | $2.97 | $1,798.42 |
DisclosureSEC source: 0001493152-26-022567 · ownership.xml · nonDerivative · entry 1 Yu Yong · CIK 0001937482 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,706 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $2.9726, and the range of prices were between $2.95 and $3.02. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 11, 2026 Filed May 13, 2026 00:30 UTC |
Zindrick ThomasPresident and CEO
|
SaleCommon Stock | 2,798 | $2.94 | $8,225.56 |
DisclosureSEC source: 0001493152-26-022566 · ownership.xml · nonDerivative · entry 1 Zindrick Thomas · CIK 0001937573 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 532,051 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $2.9398, and the range of prices were between $2.89 and $3.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| May 11, 2026 Filed May 13, 2026 00:30 UTC |
Smalling RalphHead of Regulatory
|
SaleCommon Stock | 270 | $2.98 | $804.49 |
DisclosureSEC source: 0001493152-26-022565 · ownership.xml · nonDerivative · entry 1 Smalling Ralph · CIK 0001983288 · Head of Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,803 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · price: The weighted average sale price for the transaction reported was $2.9796, and the range of prices were between $2.97 and $2.98. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| March 25, 2026 Filed Mar 26, 2026 21:00 UTC |
Smalling RalphHead of Regulatory
|
SaleCommon Stock | 240 | $2.51 | $602.40 |
DisclosureSEC source: 0001493152-26-012972 · ownership.xml · nonDerivative · entry 2 Smalling Ralph · CIK 0001983288 · Head of Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,073 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. Read SEC document |
| March 24, 2026 Filed Mar 26, 2026 21:00 UTC |
Cappello JosephChief Technical Officer
|
SaleCommon Stock | 906 | $2.42 | $2,192.52 |
DisclosureSEC source: 0001493152-26-012971 · ownership.xml · nonDerivative · entry 1 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,154 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. Read SEC document |
| March 24, 2026 Filed Mar 26, 2026 21:00 UTC |
Smalling RalphHead of Regulatory
|
SaleCommon Stock | 345 | $2.42 | $834.90 |
DisclosureSEC source: 0001493152-26-012972 · ownership.xml · nonDerivative · entry 1 Smalling Ralph · CIK 0001983288 · Head of Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,313 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. Read SEC document |
| March 24, 2026 Filed Mar 26, 2026 21:00 UTC |
Zindrick ThomasPresident and CEO
|
SaleCommon Stock | 3,582 | $2.42 | $8,668.44 |
DisclosureSEC source: 0001493152-26-012969 · ownership.xml · nonDerivative · entry 1 Zindrick Thomas · CIK 0001937573 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 534,849 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. Read SEC document |
| March 24, 2026 Filed Mar 26, 2026 21:00 UTC |
Yu YongSVP, Clinical Development
|
SaleCommon Stock | 906 | $2.42 | $2,192.52 |
DisclosureSEC source: 0001493152-26-012970 · ownership.xml · nonDerivative · entry 1 Yu Yong · CIK 0001937482 · SVP, Clinical Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,938 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 01:05 UTC |
Thomas JohnDirector
|
SaleCommon Stock | 10,000 | $2.90 | $28,957.00 |
DisclosureSEC source: 0001493152-26-008743 · ownership.xml · nonDerivative · entry 1 Thomas John · CIK 0001939103 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 482,784 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2025. F2 · price: The weighted average sale price for the transaction reported was $2.8957, and the range of prices were between $2.82 and $3.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| January 02, 2026 Filed Jan 7, 2026 22:32 UTC |
Litten JasonChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 275,000 | $0.00 Strike: $4.55 | $0.00 |
DisclosureSEC source: 0001493152-26-000854 · ownership.xml · derivative · entry 1 Litten Jason · CIK 0001909400 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 275,000 shares Expires 2036-01-01 F1 · derivative.exercise_date: The shares subject to the option will vest 25% on the first anniversary of the grant date, and the remaining shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| December 05, 2025 Filed Dec 10, 2025 01:00 UTC |
Smalling RalphHead of Regulatory
|
SaleCommon Stock | 165 | $4.69 | $773.85 |
DisclosureSEC source: 0001493152-25-026981 · ownership.xml · nonDerivative · entry 4 Smalling Ralph · CIK 0001983288 · Head of Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,658 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · balance_after: The total shown in Column 5 takes into account the transactions reported on Forms 4 filed on August 29, 2025 and September 3, 2025. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 00:00 UTC |
Thomas JohnDirector
|
SaleCommon Stock | 10,000 | $5.00 | $50,008.00 |
DisclosureSEC source: 0001493152-25-025811 · ownership.xml · nonDerivative · entry 1 Thomas John · CIK 0001939103 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 492,784 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2025. F2 · price: The weighted average sale price for the transaction reported was $5.0008, and the range of prices were between $4.73 and $5.34. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| November 17, 2025 Filed Dec 10, 2025 01:00 UTC |
Smalling RalphHead of Regulatory
|
SaleCommon Stock | 343 | $5.37 | $1,841.70 |
DisclosureSEC source: 0001493152-25-026981 · ownership.xml · nonDerivative · entry 3 Smalling Ralph · CIK 0001983288 · Head of Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,823 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · balance_after: The total shown in Column 5 takes into account the transactions reported on Forms 4 filed on August 29, 2025 and September 3, 2025. Read SEC document |
| November 17, 2025 Filed Dec 12, 2025 01:49 UTC |
Cappello JosephChief Technical Officer
|
SaleCommon Stock | 973 | $5.37 | $5,224.43 |
DisclosureSEC source: 0001493152-25-027337 · ownership.xml · nonDerivative · entry 3 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,060 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · balance_after: The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025. Read SEC document |
| November 17, 2025 Filed Dec 12, 2025 01:50 UTC |
Yu YongSVP, Clinical Development
|
SaleCommon Stock | 973 | $5.37 | $5,224.43 |
DisclosureSEC source: 0001493152-25-027338 · ownership.xml · nonDerivative · entry 2 Yu Yong · CIK 0001937482 · SVP, Clinical Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,844 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · balance_after: The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025. Read SEC document |
| November 17, 2025 Filed Dec 12, 2025 01:50 UTC |
Zindrick ThomasPresident and CEO
|
SaleCommon Stock | 4,509 | $5.37 | $24,210.62 |
DisclosureSEC source: 0001493152-25-027339 · ownership.xml · nonDerivative · entry 2 Zindrick Thomas · CIK 0001937573 · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 538,431 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · balance_after: The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025, and 1,452 shares acquired under the Issuer's Employee Stock Purchase Plan on November 14, 2025. Read SEC document |
| September 03, 2025 Filed Dec 10, 2025 01:00 UTC |
Smalling RalphHead of Regulatory
|
SaleCommon Stock | 580 | $3.36 | $1,948.22 |
DisclosureSEC source: 0001493152-25-026981 · ownership.xml · nonDerivative · entry 2 Smalling Ralph · CIK 0001983288 · Head of Regulatory 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,166 F1 · kind: Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. F2 · balance_after: The total shown in Column 5 takes into account the transactions reported on Forms 4 filed on August 29, 2025 and September 3, 2025. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:15 UTC |
Cappello JosephChief Technical Officer
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | Not disclosed Strike: $3.33 | Not disclosed |
DisclosureSEC source: 0001641172-25-026395 · ownership.xml · derivative · entry 8 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common stock · 65,000 shares Expires 2033-09-10 F2 · price: The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options. F3 · derivative.exercise_date: The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:15 UTC |
Cappello JosephChief Technical Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 65,000 | Not disclosed Strike: $22.40 | Not disclosed |
DisclosureSEC source: 0001641172-25-026395 · ownership.xml · derivative · entry 7 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 65,000 shares Expires 2033-09-10 F2 · price: The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options. F3 · derivative.exercise_date: The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:15 UTC |
Cappello JosephChief Technical Officer
|
GrantStock Option (Right to Buy) · Derivative | 13,333 | Not disclosed Strike: $3.33 | Not disclosed |
DisclosureSEC source: 0001641172-25-026395 · ownership.xml · derivative · entry 6 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,333 Underlying: Common stock · 13,333 shares Expires 2030-09-23 F2 · price: The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options. F1 · derivative.exercise_date: The shares subject to these options are fully vested. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:15 UTC |
Cappello JosephChief Technical Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 13,333 | Not disclosed Strike: $6.00 | Not disclosed |
DisclosureSEC source: 0001641172-25-026395 · ownership.xml · derivative · entry 5 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 13,333 shares Expires 2030-09-23 F2 · price: The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options. F1 · derivative.exercise_date: The shares subject to these options are fully vested. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:15 UTC |
Cappello JosephChief Technical Officer
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | Not disclosed Strike: $3.33 | Not disclosed |
DisclosureSEC source: 0001641172-25-026395 · ownership.xml · derivative · entry 4 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common stock · 80,000 shares Expires 2027-09-12 F2 · price: The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options. F1 · derivative.exercise_date: The shares subject to these options are fully vested. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:15 UTC |
Cappello JosephChief Technical Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 80,000 | Not disclosed Strike: $6.00 | Not disclosed |
DisclosureSEC source: 0001641172-25-026395 · ownership.xml · derivative · entry 3 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 80,000 shares Expires 2027-09-12 F2 · price: The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options. F1 · derivative.exercise_date: The shares subject to these options are fully vested. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:15 UTC |
Cappello JosephChief Technical Officer
|
GrantStock Option (Right to Buy) · Derivative | 16,666 | Not disclosed Strike: $3.33 | Not disclosed |
DisclosureSEC source: 0001641172-25-026395 · ownership.xml · derivative · entry 2 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,666 Underlying: Common stock · 16,666 shares Expires 2026-12-30 F2 · price: The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options. F1 · derivative.exercise_date: The shares subject to these options are fully vested. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:15 UTC |
Cappello JosephChief Technical Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 16,666 | Not disclosed Strike: $6.00 | Not disclosed |
DisclosureSEC source: 0001641172-25-026395 · ownership.xml · derivative · entry 1 Cappello Joseph · CIK 0001939198 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 16,666 shares Expires 2026-12-30 F2 · price: The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options. F1 · derivative.exercise_date: The shares subject to these options are fully vested. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:15 UTC |
Zindrick ThomasDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 250,000 | Not disclosed Strike: $3.33 | Not disclosed |
DisclosureSEC source: 0001641172-25-026398 · ownership.xml · derivative · entry 8 Zindrick Thomas · CIK 0001937573 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common stock · 250,000 shares Expires 2033-09-10 F2 · price: The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options. F3 · derivative.exercise_date: The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:15 UTC |
Zindrick ThomasDirector · President and CEO
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 250,000 | Not disclosed Strike: $22.40 | Not disclosed |
DisclosureSEC source: 0001641172-25-026398 · ownership.xml · derivative · entry 7 Zindrick Thomas · CIK 0001937573 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 250,000 shares Expires 2033-09-10 F2 · price: The transactions reported herein reflect a one-time reduction of the exercise prices of these stock options, effective September 1, 2025, to an exercise price of $3.33 per share, the price of the Issuer's common stock on September 1, 2025. There is no change to the expiration dates or the vesting schedule of the stock options. F3 · derivative.exercise_date: The shares subject to the option vest as follows: 25% on September 11, 2024, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.